Resolute Holdings (RHLD) awards director John Cote 1,452 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Resolute Holdings Management, Inc. reported that director John D. Cote received a grant of stock options. The award covers 1,452 options to buy Resolute Holdings common stock at an exercise price of $129.19 per share, expiring on June 11, 2036.
These options were granted as compensation and not purchased on the open market. Following the grant, Cote holds 1,452 derivative securities of this type. According to the footnote, the options vest in four equal annual installments of 25% starting on June 11, 2027 and on each of the next three anniversaries.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Cote John D.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,452 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,452 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 1,452 options
Exercise price: $129.19 per share
Post-grant derivative holdings: 1,452 derivative securities
+3 more
6 metrics
Option grant size
1,452 options
Stock Option (Right to Buy) granted to director John D. Cote
Exercise price
$129.19 per share
Conversion or exercise price of granted stock options
Post-grant derivative holdings
1,452 derivative securities
Total stock options held following the transaction
Expiration date
June 11, 2036
Expiration of the stock options granted to John D. Cote
Initial vesting date
June 11, 2027
First 25% tranche of options vests on this date
Vesting pattern
25% annually over 4 years
Equal annual installments starting June 11, 2027
Key Terms
Stock Option (Right to Buy), Common Stock, Grant, award, or other acquisition, vest in equal annual installments
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) granted to John D. Cote"
Common Stock financial
"underlying_security_title: Common Stock linked to the options"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition of options"
vest in equal annual installments financial
"footnote: The Stock Options will vest in equal annual installments of 25% each"
FAQ
What insider transaction did RHLD report for John D. Cote?
Resolute Holdings reported that director John D. Cote received a grant of 1,452 stock options. These options provide the right to buy common shares at a fixed exercise price as part of his equity-based compensation.
How many Resolute Holdings (RHLD) options were granted to John D. Cote?
John D. Cote was granted 1,452 stock options. Each option relates to one share of Resolute Holdings common stock, giving him potential future ownership if he chooses to exercise them.
What is the exercise price of John D. Cote’s RHLD stock options?
The stock options granted to John D. Cote have an exercise price of $129.19 per share. This is the fixed price he would pay per share if he exercises the options before expiration.
When do John D. Cote’s Resolute Holdings (RHLD) options vest?
The options vest in four equal annual installments of 25% each. Vesting starts on June 11, 2027, with additional 25% tranches on the first, second, and third anniversaries of that date.
When do John D. Cote’s RHLD stock options expire?
The stock options granted to John D. Cote expire on June 11, 2036. He must exercise any vested options before this expiration date to acquire Resolute Holdings common shares.
Is John D. Cote’s RHLD option grant an open-market purchase or compensation?
The Form 4 describes this transaction as a grant or award acquisition. The options were issued as compensation, not bought in the open market, and initially have a zero-dollar transaction price.